Dr. Carter Develops Spray-on Skin Technology for Burns, Wounds, Lowering Mortality Rate
By developing a new burn and wound care technology, known as spray-on skin, and increasing coordination between hospitals and emergency services across Louisiana, LSU School of Medicine surgeon Dr. Jeffrey Carter has helped reduce the length of hospital stays and the mortality rate from burns by more than half in several parishes.
Written by Elsa Hahne
Assistant Director of Creative Strategy
Office of Research & Economic Development
Louisiana State University
Originally published on LSU Office of Research and Economic Development website
Dr. Jeffrey Carter, associate professor of surgery at LSU Health New Orleans School
of Medicine, didn't consider crawfish and the local tradition of boiling them around
Easter when the decision was made to open their new Burn Center, part of University
Medical Center, in late March 2018. But as its medical director, he filled every bed
with patients on their first day open, as 80-quart pots with spicy seafood boil accidentally
tipped over at homes in the area, cooking not just crawfish, but skin.
Last fall, during Hurricane Ida, the Burn Center reached capacity again. As residents
fired up generators, their sole source of power for days or weeks, some of which exploded
or had fuel catching on fire, 41 people with severe burns ended up in Dr. Carter's
and his team's care.
Only a week later, Jazmyne Sylve arrived. She was pregnant and suffered severe burns
from an exploding propane grill outside her apartment complex in Slidell, as did her
partner and 6-month-old baby. Almost 40% of Sylve's body was burned, including both
legs, and since the risk of dying from a burn is calculated by adding the burn percentage
to the patient's age, her odds were not good.
Even if she survived, Sylve was expected to remain at the hospital for a minimum of
three months, according to national statistics. What Sylve didn't know, however, is
that Dr. Carter had spent over a decade developing a new technology for burn and wound
care, performing some of the first compassionate-use surgeries (using experimental
technologies to save lives that otherwise would be lost) using spray-on skin in Louisiana
even before the technology received FDA approval in 2018. It's now commercialized
under the name ReCell.
Thanks to the work of Dr. Carter, his team, and the new spray-on skin technology,
Sylve recovered quickly and was able to leave the hospital, along with her family,
in three weeks.
“Without ReCell, I would probably still be in the hospital right now,” Sylve said
last month, as she was getting ready to celebrate the holidays with her family. “If
they'd had to rely on grafts, they would have had to strip my whole back to do it,
and instead of 8-10 hours, my surgery took 2-3 hours. My left leg was all ReCell,
and unless you look closely, you can't tell I was burned at all.”
Her experience is not uncommon, according to Dr. Carter.
Part of the savings come from getting patients to the right place for the right care. By working with the
state and the Louisiana Emergency Response Network (LERN), which manages care coordination
for critically injured Louisianans, Dr. Carter is helping to make sure burn victims
are routed directly to the nearest burn center—to New Orleans, Baton Rouge, Lafayette,
or Shreveport—instead of to nearby emergency rooms. He's also working with the Louisiana
Department of Health on designing and delivering burn kits to first responders, so
people with minor burns—including fire fighters—can get immediate treatment and avoid
trips to emergency rooms and burn centers. The goal is to get burn victims faster
and better care, but also increase disaster capacity and preparedness across the state.
“Half of all burn transfers, from one place to another, are actually not needed,”
Dr. Carter said. “The challenge is that few medical professionals have education on
burns and get really scared when they get a burn patient, so they just ship them off,
and those transfers are expensive and delay care.”
Dr. Carter trains at least a dozen other doctors each month on burns and on using
the spray-on skin technology, which he began developing more than 10 years ago under
a grant from the Armed Forces Institute of Regenerative Medicine, or AFIRM. (He does
not make money from the training nor the technology, however, since he, as all LSU
faculty and staff, is a state employee. Instead, he routes proceeds to charity.)
“What's great about burn research is that it translates very quickly,” Dr. Carter
said. “While most trauma research in the civilian world doesn't translate well to
the military, where explosions and penetrating injuries are more common, burn research
does.”
Research translation is not only about relaying content, however. It's also about
educating people on how to use new technology; when, where, and why.
“Education on how to treat burns is key,” Dr. Carter continued. “We can create new
technologies, but if we don't do the education, they don't have an impact.”
When the Burn Center at University Medical Center in New Orleans opened in 2018, the
mortality rate from burns in the surrounding parishes (Orleans, Jefferson, St. Bernard,
and Plaquemines) was 7.9%, more than double the national average. Within two years,
Dr. Carter and his team got the number down to 3.6%.
“People in this region were twice as likely to die—a huge testament to the unmet needs
in this part of the country—and today, we're actually doing better than most,” Dr.
Carter said. “We've also made spray-on skin part of our hospital standard of care,
so it's offered to all patients who could benefit from it, regardless of insurance
status or ability to pay. In fact, we've been able to stay profitable simply by taking
care of everybody. That's because our average cost per patient has gone down, by getting
people home faster."
Spray-on skin is created by taking a small sample of a person's healthy skin, big as a thumbnail and thinner than a one-dollar bill, and allowing enzymes to separate the top layer of the skin, the epidermis, from the layer underneath, the dermis. Between these layers are progenitor cells, a kind of stem cell that can replicate into different types of cells. When progenitor cells are put into a solution that's sprayed over open wounds or burns, they replicate quickly, creating new skin.
While burn surgeons used to have to rely on same-sized grafts—such as a piece of skin
the size of a hand to heal a burn the size of a hand, 1:1 ratio, thus creating another
wound that can cause pain, infection, and scarring—the ReCell technology allows for
a ratio closer to 1:80 and the spray-on skin solution can be applied to donor sites
for grafts and ReCell samples as well.
In good American fashion (the innovation behind spray-on skin was originally patented
by an Australian researcher, Dr. Fiona Wood), Dr. Carter has further “supersized”
the technology. Initially used to treat an area of skin smaller than a sheet of paper,
Dr. Carter and colleagues are teaming up to use several ReCell kits at once during
one single surgery—not multiple surgeries—to treat up to 75% of a patient's skin.
The New Orleans Burn Center has become a national leader in research on burns and
their care. Dr. Carter's team is currently engaged in nine funded research projects.
One of them is a $90-million multicenter effort to develop a multispectral camera
system in combination with artificial intelligence, or AI, to help with burn patient
triage. It's funded by the Biomedical Advanced Research and Development Authority
(BARDA) and Dr. Carter is the principal investigator, working with an LSU engineering
alumnus, Sean King, on the hardware development.
“Most doctors cannot look at a burn and tell whether it requires surgery or will heal
on its own,” Dr. Carter said. “They're right about 50-60% of the time, which is not
much better than a coin flip, or just guessing. Burn surgeons do better, but not great.
We're right about 75% of the time, which means that one-quarter of our patients either
get surgery when they don't need it, or don't get surgery when they do need it. As
a result, we delay recovery and put some at additional risk of infection and complications.”
By developing AI to recognize patterns in images taken with both visible and invisible
(infrared) light and then correlating those patterns with known outcomes whenever
surgery wasn't performed—the patient healed, or didn't heal—the researchers have already
reached 91% accuracy. They haven't allowed the AI to tell them what to do yet, however—they're
still in the training phase, hoping to achieve even greater accuracy.
“The future of this technology is amazing,” said King, who graduated from LSU with
a master's degree in mechanical engineering in 2018 and now works for SpectralMD in
Texas in partnership with Dr. Carter. “It's going to save hospitals and patients a
lot of time and a lot of money. It's a win-win for everybody.”
“When you work with burn patients, you also know this—they don't like to be touched,”
Dr. Carter added. “So, any technology that doesn't contact the patient and also doesn't
expose them to lasers or ionizing radiation while assuring better outcomes is ideal.”
The camera system he and his colleagues are building will be roughly the cost and
size of an ultrasound cart, available in most urgent care settings.
Another project involves using ReCell, but in a new way, to treat hernias. These form
when organs or internal tissue break through a hole in the muscles, such as in the
abdomen. Hernia repair is one of the most common types of surgery with more than 1
million performed each year in the United States. Using the ReCell system's ability
to remove the top-most layer of skin and the progenitor cells underneath (which otherwise
could begin growing new skin inside the body), surgeons get a clean piece of dermis
to help patch the weakened region of tissue. A provisional patent for the technology
was filed last year, and a colleague of Dr. Carter's, Dr. Herb Phelan, professor of
surgery at LSU Health New Orleans and surgical critical care specialist at University
Medical Center, recently received a LIFT2 grant from the LSU Board of Supervisors
to further advance the technology.